Our Mission

Suono Bio is on a mission to revolutionize what therapeutics may be used to treat diseases. Advances in genomics have enabled a step-shift in our understanding of diseases and relevant targets to treat those diseases but delivery technologies lag. Our technology promises to deliver potentially superior therapies, like nucleic acids and gene therapies, in a simplified proprietary formulation. Suono Bio’s mission is to enable the use of the right drug at the right location in the right patient.

Meet the Team

Founders

Robert Langer, ScD
Co-​Founder

Gio Traverso, MD, PHD
Co-Founder

Carl Schoellhammer, PhD
Co-Founder, CTO

Management​

Scott Kellogg, MS, MBA
CEO

Sean Moran, CPA
Senior Management Advisor

Albert "Skip" Farinha
COO

Carl Schoellhammer, PhD
Co-Founder, CTO

Board of Directors

Fred Shane
Managing Partner, Axil Capital

Robert Langer, ScD
Co-​Founder, Suono Bio

Gio Traverso, MD, PHD
Co-Founder, Suono Bio

Carl Schoellhammer, PhD
Co-Founder, CTO, Suono Bio

Scott Kellogg, MS, MBA
CEO, Suono Bio

Scientific Advisory Board

Kenolisa Onwueme, MD, PhD
Chair, Division of Gastroenterology
University of Maryland-Baltimore Washington Medical Center